-
HVP Launches Global Initiative to Accelerate the Development of COVID-19 Vaccines
americanpharmaceuticalreview
April 26, 2020
The Human Vaccines Project (HVP), a global nonprofit consortium, is launching the COVID Vaccine Initiative (CVI) to develop safe, effective, accessible vaccines for those most vulnerable to COVID-19.
-
J&J selects Emergent BioSolutions for Covid-19 vaccine manufacturing
pharmaceutical-technology
April 26, 2020
Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutical has signed an agreement with Emergent BioSolutions for manufacturing services for its lead investigational Covid-19 vaccine candidate.
-
China approves third COVID-19 vaccine for clinical trials
expresspharma
April 26, 2020
A total of 96 persons in three age groups have received the vaccine in the first phase of clinical trial as of April 23.
-
Scancell kicks off COVID-19 vaccine development
pharmatimes
April 24, 2020
Scancell has initiated a research programme to develop a vaccine for COVID-19.
-
Emergex signs agreement with George Mason University for highly pathogenic RNA virus studies
pharmaceutical-business-review
April 24, 2020
Emergex Vaccines Holding, a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, announced that it has entered into an agreement with the George Mason University, based in Virginia, in the United States.
-
Griffith University and IIL team up to develop Covid-19 vaccine
pharmaceutical-technology
April 24, 2020
Griffith University in Australia has partnered with vaccines manufacturing company Indian Immunologicals (IIL) to develop a Covid-19 vaccine.
-
J&J strikes deal with Emergent BioSolutions on coronavirus vaccine manufacturing
expresspharma
April 24, 2020
Under the deal, valued at about $135 million, Emergent said it would provide drug substance manufacturing services and was reserving large-scale manufacturing capacity.
-
MIT researchers in US advance Covid-19 vaccine into preclinical tests
pharmaceutical-technology
April 23, 2020
A research team at the Massachusetts Institute of Technology (MIT) in the US have advanced a Covid-19 vaccine candidate into preclinical tests in animal models.
-
Germany approves trials of COVID-19 vaccine candidate
expresspharma
April 23, 2020
The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with more subjects, including some at higher risk from the disease, to be included in a second stage, German vaccines regulator the P
-
UK COVID-19 vaccine to begin human testing
pharmatimes
April 22, 2020
As of this morning – Wednesday April 22 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 129,044 with 17,337 deaths.